Anderson L, Henderson C, Adachi Y
The Wellcome Trust Centre for Cell Biology, Institute of Cell & Molecular Biology, University of Edinburgh, Edinburgh EH9 3JR, United Kingdom.
Mol Cell Biol. 2001 Mar;21(5):1719-29. doi: 10.1128/MCB.21.5.1719-1729.2001.
53BP1 is a human BRCT protein that was originally identified as a p53-interacting protein by the Saccharomyces cerevisiae two-hybrid screen. Although the carboxyl-terminal BRCT domain shows similarity to Crb2, a DNA damage checkpoint protein in fission yeast, there is no evidence so far that implicates 53BP1 in the checkpoint. We have identified a Xenopus homologue of 53BP1 (XL53BP1). XL53BP1 is associated with chromatin and, in some cells, localized to a few large foci under normal conditions. Gamma-ray irradiation induces increased numbers of the nuclear foci in a dose-dependent manner. The damage-induced 53BP1 foci appear rapidly (in 30 min) after irradiation, and de novo protein synthesis is not required for this response. In human cells, 53BP1 foci colocalize with Mrel1 foci at later stages of the postirradiation period. XL53BP1 is hyperphosphorylated after X-ray irradiation, and inhibitors of ATM-related kinases delay the relocalization and reduce the phosphorylation of XL53BP1 in response to X-irradiation. In AT cells, which lack ATM kinase, the irradiation-induced responses of 53BP1 are similarly affected. These results suggest a role for 53BP1 in the DNA damage response and/or checkpoint control which may involve signaling of damage to p53.
53BP1是一种人类BRCT蛋白,最初通过酿酒酵母双杂交筛选被鉴定为一种与p53相互作用的蛋白。尽管其羧基末端BRCT结构域与裂殖酵母中的DNA损伤检查点蛋白Crb2有相似性,但目前尚无证据表明53BP1参与检查点过程。我们鉴定出了53BP1的非洲爪蟾同源物(XL53BP1)。XL53BP1与染色质相关,在某些细胞中,正常情况下定位于少数几个大的病灶。γ射线照射以剂量依赖的方式诱导核病灶数量增加。损伤诱导的53BP1病灶在照射后迅速出现(30分钟内),且该反应不需要从头进行蛋白质合成。在人类细胞中,照射后后期53BP1病灶与Mrel1病灶共定位。X射线照射后XL53BP1发生过度磷酸化,ATM相关激酶抑制剂会延迟重新定位并减少XL53BP1对X射线照射的磷酸化反应。在缺乏ATM激酶的AT细胞中,53BP1的照射诱导反应也受到类似影响。这些结果表明53BP1在DNA损伤反应和/或检查点控制中起作用,这可能涉及向p53传递损伤信号。